DexCom Inc (NAS:DXCM)
$ 129.71 3.74 (2.97%) Market Cap: 51.58 Bil Enterprise Value: 49.79 Bil PE Ratio: 83.68 PB Ratio: 22.88 GF Score: 89/100

DexCom Inc at William Blair Growth Stock Conference Transcript

Jun 05, 2019 / 07:00PM GMT
Release Date Price: $30.87 (-1.03%)
Malgorzata Maria Kaczor
William Blair & Company L.L.C., Research Division - Research Analyst

Good afternoon, everyone. My name is Margaret Kaczor. I am the research analyst at William Blair & Company who covers DexCom. Before we begin, I am required to inform you that I personally own shares of DexCom. Beyond that, you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com.

Before I turn over to Steve, Matt and Jereme, I will say DexCom, and I think I'm allowed to say this, DexCom is our #1 most requested one-on-one meeting at this conference. And it's really, if you look at the story, it's been one of the top performing stocks on our coverage universe over the last 2 years, and it's really been driven by 2 things. So number one, you had competition enter the market. Everyone got afraid of that. And despite that fear that it was going to pressure DexCom, it actually expanded market adoption in the U.S.

And then two, the company received FDA approval for their next-generation sensor, and it was through an entirely new FDA

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot